Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 22, 2022

SELL
$0.81 - $1.34 $5,494 - $9,089
-6,783 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$1.74 - $2.4 $33,707 - $46,492
-19,372 Reduced 74.07%
6,783 $12,000
Q3 2021

Nov 15, 2021

BUY
$2.08 - $3.6 $24,042 - $41,612
11,559 Added 79.19%
26,155 $57,000
Q2 2021

Aug 12, 2021

SELL
$3.36 - $10.56 $12,294 - $38,639
-3,659 Reduced 20.04%
14,596 $51,000
Q1 2021

May 17, 2021

BUY
$9.26 - $14.36 $3,768 - $5,844
407 Added 2.28%
18,255 $180,000
Q4 2020

Feb 12, 2021

SELL
$9.84 - $14.26 $836 - $1,212
-85 Reduced 0.47%
17,848 $194,000
Q3 2020

Nov 13, 2020

SELL
$10.3 - $21.64 $15,985 - $33,585
-1,552 Reduced 7.97%
17,933 $184,000
Q2 2020

Aug 14, 2020

BUY
$8.53 - $25.64 $61,236 - $184,069
7,179 Added 58.34%
19,485 $407,000
Q1 2020

May 14, 2020

SELL
$7.98 - $16.32 $6,232 - $12,745
-781 Reduced 5.97%
12,306 $131,000
Q4 2019

Feb 13, 2020

BUY
$5.12 - $12.22 $21,524 - $51,372
4,204 Added 47.33%
13,087 $150,000
Q2 2019

Aug 14, 2019

SELL
$5.1 - $11.89 $4,488 - $10,463
-880 Reduced 9.01%
8,883 $98,000
Q1 2019

May 15, 2019

BUY
$3.03 - $6.02 $5,008 - $9,951
1,653 Added 20.38%
9,763 $51,000
Q2 2018

Aug 10, 2018

BUY
$5.3 - $6.9 $42,983 - $55,959
8,110 New
8,110 $43,000

Others Institutions Holding ADVM

About Adverum Biotechnologies, Inc.


  • Ticker ADVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,333,600
  • Market Cap $471M
  • Description
  • Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...
More about ADVM
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.